Alrestatin (sodium) - CAS 51876-97-2
Catalog number: 51876-97-2
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C14H8NNaO4
Molecular Weight:
277.21
COA:
Inquire
Targets:
Aldose Reductase
Description:
Alrestatin sodium is a specific inhibitor of aldose reductase (IC50 = 148 μM).
Publictions citing BOC Sciences Products
  • >> More
Purity:
≥98%
Appearance:
White crystalline solid
Synonyms:
Sodium;2-(1,3-dioxobenzo[de]isoquinolin-2-yl)acetate;
Solubility:
Soluble in DMSO
Storage:
Store at -20 °C
MSDS:
Inquire
Application:
A specific inhibitor of aldose reductase
Quality Standard:
Enterprise Standard
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Grams-Kilos
Melting Point:
262 - 265 °C
InChIKey:
FKZUETPACPDEAD-UHFFFAOYSA-M
InChI:
1S/C14H9NO4.Na/c16-11(17)7-15-13(18)9-5-1-3-8-4-2-6-10(12(8)9)14(15)19;/h1-6H,7H2,(H,16,17);/q;+1/p-1
Canonical SMILES:
C1=CC2=C3C(=C1)C(=O)N(C(=O)C3=CC=C2)CC(=O)[O-].[Na+]
Current Developer:
Wyeth
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Aldose Reductase Products


Aldose reductase-IN-1
(CAS: 1355612-71-3)

Aldose reductase-IN-1, an aldose reductase inhibitor, could have potential biological usage in the study of breast cancer. IC50: 28.9 pM.

CAS 110703-94-1 Zopolrestat

Zopolrestat
(CAS: 110703-94-1)

Zopolrestat is an inhibitor of Aldose Reductase(AR). It has been shown to play roles in inflammation and cancer. It is used for the treatment of diabetic nephro...

CAS 147254-64-6 Raniestat

Raniestat
(CAS: 147254-64-6)

Raniestat, a highly potent aldose reductase inhibitor currently under phase III clinical trials in the US and Canada, is used to treat diabetic neuropathies.

CAS 82964-04-3 Tolrestat

Tolrestat
(CAS: 82964-04-3)

Tolrestat is an orally active and potent aldose reductase inhibitor with IC50 value of 35 nM. It was approved for the control of certain diabetic complications....

CAS 72702-95-5 Ponalrestat

Ponalrestat
(CAS: 72702-95-5)

Ponalrestatis an aldose reductase inhibitor originator byAstraZeneca. It can block the conversion of glucose to sorbitol. Ponalrestatis shows selectivity for al...

CAS 112733-06-9 Zenarestat

Zenarestat
(CAS: 112733-06-9)

Zenarestat is an aldose reductase inhibitor. It was investigated as a treatment of diabetic neuropathy and cataract. It was developed by Fujisawa Pharmaceutical...

CAS 82159-09-9 Epalrestat

Epalrestat
(CAS: 82159-09-9)

Epalrestat is an aldose reductase inhibitor with IC50 of 72 nM.

CAS 51876-97-2 Alrestatin (sodium)

Alrestatin (sodium)
(CAS: 51876-97-2)

Alrestatin sodium is a specific inhibitor of aldose reductase (IC50 = 148 μM).

CAS 4450-98-0 EBPC

EBPC
(CAS: 4450-98-0)

EBPC is a potent and selective aldose reductase inhibitor. It is used to improve the cytotoxicity of anticancer reagents such as cisplatin and doxorubicin in He...

CAS 961-29-5 Isoliquiritigenin

Isoliquiritigenin
(CAS: 961-29-5)

Isoliquiritigenin, an anti-tumor flavonoid from the root of Glycyrrhiza glabra, inhibiting aldose reductase with an IC50 of 320 nM.

CAS 51411-04-2 Alrestatin

Alrestatin
(CAS: 51411-04-2)

Alrestatin is an inhibitor of aldose reductase (IC50 = 148 μM).

CAS 105346-34-7 FR-62765

FR-62765
(CAS: 105346-34-7)

FR-62765, a derivative of WF-3681, is a novel aldose reductase inhibitor. It might be a useful drug for diabetic neuropathy.

Chemical Structure

CAS 51876-97-2 Alrestatin (sodium)

Quick Inquiry

Verification code

Featured Items